Article By:
The Life Sciences Report
Friday, August 14, 2015 4:13 AM EDT
Volatility is the nature of the biotech beast, and it must be tamed or utilized to advantage. That's the philosophy of Eden Rahim, portfolio manager and option strategist at Theta Strategies Capital.
In this article: ABT, AGN, SGYP, RPTP, MBXBF, PWCDF, RHHBY, SSDOY, ACAD, DNDN, FOLD, HALO, ILMN, MDVN, AMGN, BIIB, SHPG, REPCF, SUPN, BCLI, ITEK, RARE, PTLA, CPHR, PTGEF, BLUSF